In such circumstances (Figure 3), the administration of selective serotonin reuptake inhibitors (SSRIs) sertraline and fluoxetine may have been considered, given the drug’s reported ability to reduce levels of anxiety, proinflammatory cytokines and IgE in AD patients [66,67,68,69,70]. The gene discussed is IGHE; the disease is Alzheimer disease.